Viking Therapeutics, Inc. (VKTX)
33.23
-0.66
(-1.95%)
USD |
NASDAQ |
Aug 24, 16:00
33.25
+0.02
(+0.06%)
After-Hours: 20:00
Viking Therapeutics 1 Year Total Returns (Daily) : 27.81% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 27.81% |
| August 21, 2026 | 32.07% |
| August 20, 2026 | 33.75% |
| August 19, 2026 | 47.70% |
| August 18, 2026 | -20.72% |
| August 17, 2026 | -15.99% |
| August 14, 2026 | -17.52% |
| August 13, 2026 | -20.18% |
| August 12, 2026 | -14.65% |
| August 11, 2026 | -11.50% |
| August 10, 2026 | -9.11% |
| August 07, 2026 | -3.66% |
| August 06, 2026 | 4.45% |
| August 05, 2026 | -1.53% |
| August 04, 2026 | -3.06% |
| August 03, 2026 | -0.21% |
| July 31, 2026 | -2.55% |
| July 30, 2026 | -1.78% |
| July 29, 2026 | 1.58% |
| July 28, 2026 | 1.99% |
| July 27, 2026 | 1.31% |
| July 24, 2026 | 3.85% |
| July 23, 2026 | 5.96% |
| July 22, 2026 | 16.23% |
| July 21, 2026 | 18.82% |
| Date | Value |
|---|---|
| July 20, 2026 | 13.65% |
| July 17, 2026 | 15.62% |
| July 16, 2026 | 14.99% |
| July 15, 2026 | 23.16% |
| July 14, 2026 | 20.04% |
| July 13, 2026 | 22.53% |
| July 10, 2026 | 24.19% |
| July 09, 2026 | 35.33% |
| July 08, 2026 | 32.36% |
| July 07, 2026 | 53.14% |
| July 06, 2026 | 37.32% |
| July 02, 2026 | 35.06% |
| July 01, 2026 | 40.53% |
| June 30, 2026 | 47.21% |
| June 29, 2026 | 49.10% |
| June 26, 2026 | 35.04% |
| June 25, 2026 | 36.54% |
| June 24, 2026 | 40.52% |
| June 23, 2026 | 40.02% |
| June 22, 2026 | 24.45% |
| June 18, 2026 | 15.60% |
| June 17, 2026 | 14.60% |
| June 16, 2026 | 9.98% |
| June 15, 2026 | 13.61% |
| June 12, 2026 | 0.59% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Vertex Pharmaceuticals, Inc. | 38.59% |
| Eli Lilly & Co. | 76.32% |
| Regeneron Pharmaceuticals, Inc. | 41.25% |
| Skye Bioscience, Inc. | -91.76% |
| Eledon Pharmaceuticals, Inc. | 31.15% |